CSIMarket
 


Scynexis inc   (SCYX)
Other Ticker:  
 
 

SCYX's Operating Income Growth by Quarter and Year

Scynexis Inc 's Operating Income results by quarter and year




SCYX Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -15.33 -14.11 -8.79
III Quarter September - -11.51 -11.76 -6.30
II Quarter June -17.51 -11.83 -11.20 -7.66
I Quarter March -1.59 -12.48 -11.86 -7.23
FY   -19.10 -51.15 -48.93 -29.98



SCYX Operating Income second quarter 2021 Y/Y Growth Comment
Scynexis inc in the second quarter recorded Operating Loss of $ -17.51 millions.

According to the results reported in the second quarter, Scynexis Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Scynexis Inc ' s Operating Income no change of % ranks overall at the positon no. in the second quarter.

Explain Operating Income growth


SCYX Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Scynexis Inc 's second quarter 2021 Operating Income $ -17.51 millions SCYX's Income Statement
Scynexis Inc 's second quarter 2020 Operating Income $ -11.83 millions Quarterly SCYX's Income Statement
New: More SCYX's historic Operating Income Growth >>


SCYX Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Scynexis Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCYX's II. Quarter Q/Q Operating Income Comment
II. Quarter 2021 Operating Loss of -17.51 millions by Scynexis inc come out even less good considering the -1.59 millions Operating Loss in the previous quarter.

Within Major Pharmaceutical Preparations industry Scynexis inc achieved highest sequential Operating Income growth. While Scynexis Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCYX's II. Quarter Q/Q Operating Income Comment
II. Quarter 2021 results of -17.51 millions by Scynexis inc appear even less good compare to the Operating Loss -1.59 millions a quarter before.

Within Major Pharmaceutical Preparations industry Scynexis inc achieved highest sequential Operating Income growth. While Scynexis Inc 's Operating Income growth quarter on quarter, overall rank is .


Scynexis Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
Cumulative Operating Income 12 Months Ending $ -45.95 $ -40.26 $ -51.15 $ -49.92 $ -50.17
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Scynexis inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Scynexis inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
SCYX's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for SCYX's Competitors
Operating Income Growth for Scynexis Inc 's Suppliers
Operating Income Growth for SCYX's Customers

You may also want to know
SCYX's Annual Growth Rates SCYX's Profitability Ratios SCYX's Asset Turnover Ratio SCYX's Dividend Growth
SCYX's Roe SCYX's Valuation Ratios SCYX's Financial Strength Ratios SCYX's Dividend Payout Ratio
SCYX's Roa SCYX's Inventory Turnover Ratio SCYX's Growth Rates SCYX's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Jun 30 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Jun 30 2021
Royalty Pharma Plc81.99%$ 81.985 millions
Charles River Laboratories International inc 79.18%$ 79.176 millions
Addus Homecare Corporation77.45%$ 77.454 millions
Icu Medical Inc76.26%$ 76.263 millions
Becton Dickinson And Company75.42%$ 75.419 millions
Bio techne Corp74.47%$ 74.471 millions
Bristol Myers Squibb Co74.07%$ 74.074 millions
Apollo Medical Holdings Inc 62.62%$ 62.622 millions
United Therapeutics Corporation58.15%$ 58.149 millions
Amedisys Inc56.48%$ 56.483 millions
Catalyst Pharmaceuticals Inc 54.04%$ 54.038 millions
Avantor Inc 52.88%$ 52.881 millions
Dexcom Inc 48.97%$ 48.968 millions
Encompass Health Corporation48.12%$ 48.122 millions
Catalent Inc 47.65%$ 47.650 millions
Diversicare Healthcare Services Inc 46.08%$ 46.083 millions
Nature s Sunshine Products inc 43.73%$ 43.727 millions
Mednax Inc 43.28%$ 43.279 millions
Medpace Holdings inc 40.89%$ 40.892 millions
Mettler Toledo International Inc39.55%$ 39.550 millions
Vanda Pharmaceuticals Inc 34.87%$ 34.871 millions
Idexx Laboratories Inc34.16%$ 34.156 millions
Surgery Partners Inc 33.11%$ 33.110 millions
National Research Corporation31.96%$ 31.957 millions
Acadia Healthcare Company Inc 30.18%$ 30.176 millions
Zoetis Inc 28.99%$ 28.991 millions
Baxter International Inc 28.10%$ 28.097 millions
Innoviva inc 27.38%$ 27.377 millions
Hca Healthcare Inc 25.74%$ 25.745 millions
Tenet Healthcare Corp24.42%$ 24.416 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IIVI's Profile

Stock Price

IIVI's Financials

Business Description

Fundamentals

Charts & Quotes

IIVI's News

Suppliers

IIVI's Competitors

Customers & Markets

Economic Indicators

IIVI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071